Statistics
Publications
11
Citations
1.4K
H-Index
10
Active since
2019
Daijing Yuan is an author at Regend Therapeutics (China) specializing in cancer immunotherapy, oncology, and medicine.
Publications per year
2019–2025
11
11
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text
Medicine, Oncology, Pharmacokinetics +17
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
Changsong Qi, Chang Liu, Jifang Gong et al. · Nature Medicine · 2024 · 178 citations
Medicine, Immunology, Oncology +13
Chang Liu, Zhi Peng, Yanqiao Zhang et al. · The Lancet · 2025 · 105 citations · Full text
1–5 of 11